Core Viewpoint - Glow Holdings, Inc. has launched a new corporate website to enhance its digital presence and provide stakeholders with access to corporate information and updates on its developments in the healthtech sector [1][3]. Group 1: Company Overview - Glow Holdings, Inc., operating as GlohCo, is focused on developing AI-powered software and data-driven tools for mental health, behavioral health, and social determinants of health [4]. - The company aims to serve various stakeholders, including hospitals, insurance companies, treatment centers, and behavioral health organizations [2]. Group 2: Website Launch and Purpose - The new website serves as a central digital presence for investors, shareholders, and stakeholders, offering access to corporate information, leadership details, press releases, and investor relations materials [1]. - The website is expected to be updated regularly as the company achieves new milestones in platform development, partnerships, and corporate governance [3]. Group 3: Industry Engagement - Following a corporate transition announcement in January 2026, the company has engaged with the behavioral health sector, reaching out to clinicians, treatment center operators, and multi-state providers in South Florida [2].

Core Viewpoint - Premier Health of America Inc. has reported a significant decline in revenues and gross margin for the first quarter ended December 31, 2025, compared to the same period in 2024, while focusing on cost reduction and operational efficiency [2][3][4]. Financial Performance - Revenues for the first quarter were CAD 17.835 million, down from CAD 32.132 million in the same quarter of 2024, representing a decrease of approximately 44.4% [2]. - Gross margin decreased to CAD 2.726 million, with a gross margin percentage of 15.28%, compared to CAD 5.137 million and 16.0% in the previous year [2]. - Adjusted EBITDA fell to CAD 5, down from CAD 705,000 in the same period last year, indicating a significant decline in operational profitability [2][8]. - The net loss for the quarter was CAD 2.549 million, compared to a net loss of CAD 2.261 million in the same quarter of 2024 [2][8]. Operational Highlights - The travel nurse and northern communities services are performing well overall, except for a decline in British Columbia due to a service acquisition centralization initiative by health authorities [3]. - The company has formally discontinued its Per Diem and Transportation operations, reallocating resources to focus on Travel Nurse operations across Canada [3][4]. - The interim CEO emphasized ongoing efforts in cost reduction, debt management, and operational efficiency, with a commitment to pursuing organic growth opportunities [4]. Company Overview - Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced healthcare services to governments, companies, and individuals [6]. - The company utilizes its proprietary LiPHe platform to drive digital transformation in the healthcare services sector, aiming to provide faster, more affordable, and accessible care [6].

Masimo Founder Joe Kiani On The Healthtech Company’s $10 Billion Acquisition https://t.co/twE5qYVHnH (📸: Ethan Pines for Forbes) https://t.co/LPKl8nJPaO ...

Core Viewpoint - Auddia Inc. is set to merge with Thramann Holdings, forming a new holding company named McCarthy Finney, with a new ticker symbol MCFN, and Auddia shareholders will own approximately 20% of the new entity at closing [1][4][6]. Company Overview - Auddia Inc. operates in the audio technology sector, focusing on reinventing consumer engagement with audio content through its proprietary AI platform [10]. - Thramann Holdings is a privately held company that controls three early-stage AI-native companies: LT350, Influence Healthcare, and Voyex, founded by Jeff Thramann, who has extensive experience in securing patents and taking companies public [2][3]. Merger Details - The merger agreement has been unanimously approved by the boards of both companies and is expected to close in the second quarter of 2026, subject to customary closing conditions [6]. - Upon completion, Auddia will be renamed McCarthy Finney, and Jeff Thramann will continue as CEO, with John Mahoney as CFO [3][4]. Financial Valuation - The base case discounted cash flow (DCF) valuation of McCarthy Finney is estimated to be $250 million, based on a forward-looking 10-year pro forma analysis [5]. - Auddia must have at least $12 million in cash on hand at closing to ensure a cash runway for future business milestones [4]. Ownership Structure - At the closing of the merger, Auddia shareholders are expected to own 20% of McCarthy Finney, while Jeff Thramann will own 80% [4].

HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Glow Holdings, Inc. (OTC: GLOH), doing business as GlohCo, today provided a corporate update following the recent introduction of its GlohCo health intelligence platform and initial engagement across the mental and behavioral health sector. Following its January announcement, management engaged with clinicians, treatment center owners, operators, and business development leaders across mental health, behavioral health, and substance use disorder care, including par ...

Core Insights - Premier Health of America Inc. has filed its Audited Annual Consolidated Financial Statements and MD&A for the year ended September 30, 2025, indicating a challenging financial performance with significant net losses and a decline in revenues compared to the previous year [1][2]. Financial Performance - For Q4 2025, revenues were CAD 20.79 million, down from CAD 33.46 million in Q4 2024, representing a decrease of approximately 37.9% [2]. - The gross margin for Q4 2025 was CAD 3.45 million, with a gross margin percentage of 16.6%, slightly up from 15.9% in Q4 2024 [2]. - Adjusted EBITDA for Q4 2025 was CAD 440,000, a decline from CAD 995,000 in the same period of 2024 [2][9]. - The net loss for Q4 2025 was CAD 6.5 million, compared to a loss of CAD 2.3 million in Q4 2024, indicating a worsening financial situation [2][9]. Segment Performance - The Per Diem segment, impacted by Quebec's Bill 10, represented less than 1% of Q4 revenue and less than 4% of total revenues for the year, leading to its abandonment in Q1 2026 [3]. - Travel nurse and northern communities' services performed well overall, except in British Columbia, where a volume reduction was noted due to centralization efforts by health authorities [4]. - The company is reorganizing its Quebec operations, reducing workforce and corporate structure to achieve cost savings, with a reduction in salary expenses by CAD 0.7 million in Q4 2025 compared to Q4 2024 [5][6]. Strategic Focus - The company is shifting its focus entirely to Travel Nurses after abandoning the Per Diem segment and is exploring opportunities in the Home Care sector [6]. - Cost reduction, debt management, and operational efficiency remain priorities, alongside pursuing organic growth opportunities [6].

Core Viewpoint - Glow Holdings, Inc. has transitioned into a healthtech-focused public company following a corporate reset completed in 2025, introducing its proprietary GlohCo health intelligence platform with an initial focus on mental and behavioral health [1][5] Company Overview - GlohCo aims to leverage data, analytics, and emerging technologies to provide modern care organizations with insights into workflows, risk, and outcomes, supporting decision-making in digital health and care delivery environments [2] - The company had limited operations prior to 2025 and underwent a custodianship and change of control, resulting in new ownership and a strategic reset [3] Strategic Developments - In late October 2025, Glow Holdings, Inc. acquired an operating healthcare staffing business, which provided active industry operations and recurring service revenue, establishing a foundation for near-term business activity [4] - Management views the staffing operations as an enabling layer that supports platform development through exposure to real-world workflows and operational environments [4] Leadership Perspective - The President of Glow Holdings, Inc. emphasized the priority of restoring compliance and establishing a solid foundation for the company, with ongoing efforts to build the GlohCo platform focused on healthtech intelligence and data-informed tools [5]

As filed with the Securities and Exchange Commission on December 10, 2025 Registration No. 333- 290302 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LYTUS TECHNOLOGIES HOLDINGS PTV. LTD. (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 7841 Not applicable (I.R.S. Employer Identification Number) (State or Other Jurisdiction of Incorporation or Organization) Classification ...

Core Viewpoint - SKG has launched a new lineup of smart massagers, including the H7 Ultra, G7 Pro Fold, and YS100 Foot Massager, aimed at providing innovative, comfortable, and health-focused solutions for muscle tension relief during the holiday season [1]. Company Overview - SKG has been a leader in personal wellness technology for nearly 20 years, specializing in healthtech devices that are fashionable, affordable, and impactful [3]. - The company has ranked as the top smart massager for the past three years and is Sullivan certified [3]. Product Features H7 Ultra - The H7 Ultra offers deep tissue massage with adjustable intensity levels, targeting muscle knots and stiffness, making it ideal for individuals with "tech-neck" [5]. - It features a design that mimics human hands with 360° kneading covers, providing effective pain relief [6]. - The massager includes three speed levels and three strength levels for customizable intensity [7]. - It automatically shuts off after 15 minutes to prevent over-stimulation [8]. - The ergonomic design is optimized for a 60° angle to fit the neck comfortably [9]. - It incorporates 64 red light beads and a large heating area for deep muscle relaxation and pain relief [10]. - The lightweight design enhances portability, making it a stylish gift option [11]. G7 Pro Fold - The G7 Pro Fold is lighter than the H7 Ultra, weighing just 260g, and is designed for portability [14]. - It can be used in various settings, including the office and while traveling, providing on-the-go pain relief [15]. - The device features a 6kHz mid-frequency pulse and a 7,500 RPM motor for effective deep tissue relief [16]. - It includes 7 red lights for enhanced healing and pain relief in the neck and shoulders [17]. - The massager is made from high-quality PU leather and memory foam, allowing for a comfortable fit and customizable settings via a smartphone app [18]. YS100 Foot Massager - The YS100 is designed for deep tissue relief in the feet, beneficial for individuals with foot pain, diabetes, or high blood pressure [19]. - It offers 360° air compression with three speed and intensity settings, utilizing 12 massage heads for comprehensive foot relief [20]. - The heat setting can reach up to 131°F, enhancing pain relief effectiveness [20]. - The design accommodates feet up to US Men's size 13 and can be used at various angles [20]. - The breathable inner liner is easy to clean, ensuring hygiene with regular use [21].

Core Insights - The UK government has made several fiscal policy changes aimed at supporting the tech sector and encouraging investment in startups and scaleups, which is seen as a positive move for the industry [3][4][10]. Taxation and Incentives - The decision not to introduce a targeted wealth tax is viewed favorably, as it would have negatively impacted private investments, particularly in high-growth startups [1]. - Maintaining R&D tax credits is crucial for SMEs, providing them with the stability needed for future planning [1]. - The widening of Enterprise Management Incentives (EMIs) is a significant development, allowing small businesses to offer share options without National Insurance or income tax liabilities, thus aiding in talent retention [2][10]. - Increasing the caps on the Enterprise Investment Scheme (EIS) is noteworthy, as it will enable promising scaleups to access more capital for growth [2][10]. Government Initiatives - The Chancellor announced plans to enhance the Enterprise Investment Scheme to further encourage investment in UK startups and scaleups [3]. - A £300 million allocation to technology in the NHS aims to strengthen the AI innovation ecosystem, with a focus on translating this investment into tangible benefits for patients [6][7]. - The establishment of an AI Growth Lab and a Sovereign AI Unit is intended to scale national capabilities in AI, with the potential to add £400 billion to the UK economy by 2030 [8]. Industry Perspectives - Founders in the tech sector emphasize the need for the government to act as a customer for startups, particularly in AI, to drive productivity and innovation [5]. - Industry leaders highlight the importance of broader economic stability for the tech ecosystem to reach its full potential, as private investment in UK AI lags significantly behind the US [9]. - The Budget includes initiatives to strengthen the innovation ecosystem, such as entrepreneurship fellowships and the British Business Bank's efforts to attract institutional investment into UK scaleups [11][12]. Research and Development - The UKRI is deploying over £38.6 billion towards government priorities, indicating a significant public investment in the early stages of scientific discovery [13]. - There is a call for greater incentives for private individuals and foundations to support early scientific discovery, as current public funding models place the risk on taxpayers without sharing the rewards [14].